|
Field
Trial Status
|
Before
in_development
|
After
on_going
|
|
Field
Trial End Date
|
Before
April 30, 2018
|
After
April 30, 2019
|
|
Field
Last Published
|
Before
September 28, 2017 09:13 AM
|
After
September 28, 2017 04:48 PM
|
|
Field
Primary Outcomes (End Points)
|
Before
Take-up of contraceptives (by type of method), perceived pregnancy status or degree of uncertainty about pregnancy status, and receipt of ANC during the follow-up period as well as value of pregnancy test (Willingness to pay).
|
After
Use of any modern family planning method, perceived pregnancy status or degree of uncertainty about pregnancy status, and receipt of ANC during the follow-up period as well as value of pregnancy test (Willingness to pay).
|
|
Field
Primary Outcomes (Explanation)
|
Before
We will construct measures for the following FP-related outcomes: use of oral contraceptives, use of injectables, use of other short-acting method, and use of long-active reversible method. For ANC-related outcomes, we will measure any ANC visit, gestational age at first ANC visit, and number of ANC visits. Demand for pregnancy test kit is computed by Becker-DeGroot-Marschak (BDM) or/and Take it or leave it (TIOLI) method.
|
After
We will construct measures for the following FP-related outcomes: use of any short-acting method and use of long-active reversible method. For ANC-related outcomes, we will measure any ANC visit, gestational age at first ANC visit, and number of ANC visits. Demand for pregnancy test kit is computed by Becker-DeGroot-Marschak (BDM) or/and Take it or leave it (TIOLI) method.
|
|
Field
Experimental Design (Public)
|
Before
Following baseline data collection, around half of the sample will be provided with a home pregnancy test to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors.
|
After
Following baseline data collection, around 60% of the sample will be provided with a home pregnancy test to assess how resolving uncertainty about pregnancy status affects beliefs and behaviors.
|